TickerFacts.

Lipella Pharmaceuticals Inc. (LIPO): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-8, first reflected in a filing dated 2024-11-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

1.21M
As of 2024-12-31
4.62M
As of 2025-09-30
5.74M2021-12-31: 3.87M2022-12-31: 5.74M2023-12-31: 756.7K2024-12-31: 1.21M1.21M
2021-12-31 Shares Outstanding (shares) 2024-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2024-12-311.21M+59.8%2025-03-28, Balance as of period end
2023-12-31756.7Kn/c2025-03-28, Balance as of period end
2022-12-315.74Mn/c2024-02-27, Balance as of period end
2021-12-313.87Mn/a2023-03-31, Balance as of period end